Physician profile
Stacey T Gin
NPI 1619085149
$8,401.99
in general payments reported to CMS, 2019-2025
18 companies · $946 in 2025
The $946 reported for 2025 was more than what 90% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $970 · 2020: $417 · 2021: $660 · 2022: $1,431 · 2023: $3,082 · 2024: $896 · 2025: $946.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,071 · Entertainment: $853.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,071.36 |
| Entertainment | $852.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $2,482.23 | 2022-2023 | Optilight |
| Coopervision INC. | $1,671.56 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens, Misight Contact Lens |
| Optos, INC. | $1,330.87 | 2019-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Alcon Vision LLC | $693.89 | 2021-2024 | Total30, Precision 1, Dailies Total1 |
| Abb Con-Cise Optical Group LLC | $388.32 | 2019-2025 | Contact Lens, Spectacle Lenses |
| Johnson & Johnson Vision Care, INC. | $295.63 | 2019-2022 | |
| Topcon Healthcare, INC. | $292.31 | 2022 | |
| Bausch & Lomb Americas INC. | $292.14 | 2025 | Infuse |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $256.16 | 2019 | |
| Lkc Technologies, INC. | $172.37 | 2024 | |
| Maculogix, INC. | $154.02 | 2019 | |
| Sight Sciences, INC. | $107.21 | 2019-2023 | Tearcare System |
| Abbvie INC. | $86.68 | 2023 | |
| Biotissue Holdings INC. | $72.86 | 2022-2023 | |
| Allergan, INC. | $48.90 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $24.76 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Novartis Pharmaceuticals Corporation | $12.68 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacey Gin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.